Skip to content
10-Q

Quarterly Report

Lucira Health, Inc.

0000950170-22-025095

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 7, 2022 40.6M sh
Shares Diluted Q3 2022 · Sep 30, 2022 40.22M sh
Shares Diluted Q3 2022 · Sep 30, 2022 39.97M sh
Shares Diluted Q3 2022 · Sep 30, 2021 38.67M sh
Shares Diluted Q3 2022 · Sep 30, 2021 33.35M sh
Capex Q3 2022 · Sep 30, 2022 $21.4M
Capex Q3 2022 · Sep 30, 2021 $10.78M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$72.32M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$90.84M
Long Term Debt Q3 2022 · Sep 30, 2022 $29.41M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $39.77M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $105.98M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $117.29M
Stockholders Equity Q3 2022 · Sep 30, 2022 $60.89M
Stockholders Equity Q3 2022 · Jun 30, 2022 $185.07M
Stockholders Equity Q3 2022 · Dec 31, 2021 $188.8M
Stockholders Equity Q3 2022 · Sep 30, 2021 $193.99M
Stockholders Equity Q3 2022 · Jun 30, 2021 $215.8M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$62.31M
Current Liabilities Q3 2022 · Sep 30, 2022 $82.52M
Current Liabilities Q3 2022 · Dec 31, 2021 $50.33M
Total Liabilities Q3 2022 · Sep 30, 2022 $128.3M
Total Liabilities Q3 2022 · Dec 31, 2021 $51.55M
Current Assets Q3 2022 · Sep 30, 2022 $120.47M
Current Assets Q3 2022 · Dec 31, 2021 $206.28M
Total Assets Q3 2022 · Sep 30, 2022 $189.19M
Total Assets Q3 2022 · Dec 31, 2021 $240.35M
Eps Diluted Q3 2022 · Sep 30, 2022 −$3.15
Eps Diluted Q3 2022 · Sep 30, 2022 −$3.39
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.71
Eps Diluted Q3 2022 · Sep 30, 2021 −$1.71
Eps Basic Q3 2022 · Sep 30, 2022 −$3.15
Eps Basic Q3 2022 · Sep 30, 2022 −$3.39
Eps Basic Q3 2022 · Sep 30, 2021 −$0.71
Eps Basic Q3 2022 · Sep 30, 2021 −$1.71
Sga Expense Q3 2022 · Sep 30, 2022 $17.6M
Sga Expense Q3 2022 · Sep 30, 2022 $50.13M
Sga Expense Q3 2022 · Sep 30, 2021 $11.79M
Sga Expense Q3 2022 · Sep 30, 2021 $23.99M
Rd Expense Q3 2022 · Sep 30, 2022 $9.14M
Rd Expense Q3 2022 · Sep 30, 2022 $32.09M
Rd Expense Q3 2022 · Sep 30, 2021 $14.34M
Rd Expense Q3 2022 · Sep 30, 2021 $30.74M
Net Income Q3 2022 · Sep 30, 2022 −$126.86M
Net Income Q3 2022 · Sep 30, 2022 −$135.46M
Net Income Q3 2022 · Mar 31, 2022 $13.1M
Net Income Q3 2022 · Sep 30, 2021 −$27.5M
Net Income Q3 2022 · Sep 30, 2021 −$57.01M
Operating Income Q3 2022 · Sep 30, 2022 −$126.29M
Operating Income Q3 2022 · Sep 30, 2022 −$133.87M
Operating Income Q3 2022 · Sep 30, 2021 −$27.61M
Operating Income Q3 2022 · Sep 30, 2021 −$57.13M
Gross Profit Q3 2022 · Sep 30, 2022 −$99.56M
Gross Profit Q3 2022 · Sep 30, 2022 −$51.65M
Gross Profit Q3 2022 · Sep 30, 2021 −$1.48M
Gross Profit Q3 2022 · Sep 30, 2021 −$2.4M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $133.95M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $202.66M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $14.84M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $32.71M
Revenue Q3 2022 · Sep 30, 2022 $34.39M
Revenue Q3 2022 · Sep 30, 2022 $151.01M
Revenue Q3 2022 · Sep 30, 2021 $14.98M
Revenue Q3 2022 · Sep 30, 2021 $31.93M